Trastuzumab Completed Phase 2 Trials for Stage IV Breast Cancer / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer